Back

Do we follow evidence-based recommendations for NOACs dosing? Results from a nationwide cross-sectional registry.

27 August 2018 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Atrial fibrillation - Stroke prevention 2 Oral Anticoagulation ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Lubos Urban

The National Institute of Cardiovascular Diseases, Bratislava (Slovakia)

10 More presentations in this session

Presentation thumbnail
Associate Professor B. Hudzik (Zabrze, PL)
Abstract Slides
Presentation thumbnail
Doctor G. Simonyi (Budapest, HU)
Abstract Slides
Presentation thumbnail
Professor R. De Caterina (Pisa, IT)
Abstract Slides
Presentation thumbnail
Ms L. Pracht (Munich, DE)
Abstract
Presentation thumbnail
Doctor O. Rutherford (Sarpsborg, NO)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 5 - Atrial fibrillation - Stroke prevention 2

The Event

Event poster

ESC Congress 2018

27 August 2018 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Prevalence and risk of DOACs inappropriate dosing in atrial fibrillation. An analysis of the Swiss-AF and BEAT-AF registries
1 September 2019
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
19 July 2023
thumbnail
Congress Presentation
One year after the 2021 EHRA practical guide on NOACs: main points and new aspects.
3 April 2022
thumbnail
Webinar
Anticoagulation challenges in older subjects with multimorbidity
25 July 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources